Authors:
David Spetzler, Nick Xiao, Ken Burnett, Katie Burch, Brian Abbott, Kenneth Russell, Andreas Voss, Zoran Gatalica, Sandeep Reddy, Robert Leonard, David Khayat, John Marshall
Background
A prospective, observational study was initiated in 2009 with IRB approval to track outcomes and determine the clinical utility of multi-platform molecular profiling (MMP) across a variety of solid tumors. A secondary objective was to assess the impact of MMP on physicians’ treatment decisions.
Download PublicationCookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |